| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/28/2004 | EP1383501A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1136194C Method for producing particles of hydrory pyrithione salts |
| 01/28/2004 | CN1136191C Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683185 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines |
| 01/27/2004 | US6683142 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
| 01/27/2004 | US6683124 Fluorescent pigment compositions |
| 01/27/2004 | US6683094 4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl) -alpha-(hydroxymethyl)-alpha-methyl-benzeneacetic acid derivatives |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683087 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 01/27/2004 | US6683083 Using less toxic agents such as 1-(1-4-(diphenylmethyl)-piperazinyl)-3-(1-(4-(4-chlorophenyl)-4 -hydroxy)piperidinyl)-2-propanol; inhibiting fibroblast proliferation |
| 01/27/2004 | US6683079 Reverse transcriptase inhibitors |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/22/2004 | WO2004007510A1 Novel chemical substance having activity for morphogenesis and growth promotion |
| 01/22/2004 | WO2004007493A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 01/22/2004 | WO2004007455A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/22/2004 | WO2004007454A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 01/22/2004 | WO2004007453A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 01/22/2004 | WO2004007407A2 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 01/22/2004 | WO2004006927A2 Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors |
| 01/22/2004 | WO2004006926A1 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 01/22/2004 | WO2004006925A1 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 01/22/2004 | WO2004006924A1 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol |
| 01/22/2004 | WO2004006923A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 01/22/2004 | WO2004006922A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 01/22/2004 | WO2002072093A3 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 01/22/2004 | US20040014976 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/22/2004 | US20040014971 N-(4-(4-(2-oxo-1-phenyl-2-((2,2,2-trifluoroethyl)amino)ethyl)-1 -piperazinyl)-phenyl)-4'-(trifluoromethyl)-(1,1'-biphenyl)-2-carboxamide for treatment of obesity, diabetes, and cardiovascular disorders; decreases apoplioprotein secretion |
| 01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
| 01/22/2004 | US20040014786 Procee for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2-3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 01/22/2004 | US20040014785 Cardiovascular disorders; antiischemic agents |
| 01/22/2004 | US20040014784 Substituted propargylamines |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014770 Tachykinin antagonist |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/22/2004 | US20040014745 Amide compounds |
| 01/22/2004 | DE10230750A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten New pharmaceutical compositions based on new Anticholonergika and NK1 receptor antagonists |
| 01/22/2004 | DE10228132A1 Amide cyclischer Aminosäuren als PDE 4 Inhibitoren Amides of cyclic amino acids as PDE 4 inhibitors |
| 01/22/2004 | CA2493374A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/22/2004 | CA2492251A1 Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors |
| 01/22/2004 | CA2492086A1 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 01/22/2004 | CA2492083A1 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1381668A1 Compounds, compositions, and methods for controlling biofilms |
| 01/21/2004 | EP1381602A1 Heterocyclyldicarbamides as caspase inhibitors |
| 01/21/2004 | EP1381594A1 Urea compounds useful as anti-inflammatory agents |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
| 01/21/2004 | CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same |
| 01/21/2004 | CN1469860A Aza-amino acid derivatives (factor XA-inhibitors 15) |
| 01/21/2004 | CN1468851A Synthesis of pyridine pentachloride |
| 01/21/2004 | CN1135252C Resin composition, polyurethane fibre, process for preparing polyurethane fiber, and elastic braided fabric |
| 01/21/2004 | CN1135222C Synthesis of cisapride |
| 01/20/2004 | US6680334 A new crystalline, pharmaceutically acceptable form of amlodipine free base; antiischemic agents; hypotensive agents; cardiotonic agents; storage stability; isolating amlodipine free base, crystallising using solvent(s) |
| 01/20/2004 | US6680329 N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants |
| 01/20/2004 | US6680321 4-((1-piperazinylmethyl)-benzamide derivatives; hypotensive agents; immunomodulators |
| 01/20/2004 | US6680320 Urokinase inhibitors |
| 01/20/2004 | US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders |
| 01/15/2004 | WO2004005257A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 01/15/2004 | WO2004005256A2 Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors |
| 01/15/2004 | WO2004005255A1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/ or serotonin reuptake inhibitors |
| 01/15/2004 | WO2004005254A1 Process for producing piperidine compound |
| 01/15/2004 | WO2004004724A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 01/15/2004 | WO2004004722A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/15/2004 | US20040010159 Blends of quinone alkide and nitroxyl compounds and polymerization inhibitors |
| 01/15/2004 | US20040010147 Cyclic amine compounds and pharmaceutical composition containing the same |
| 01/15/2004 | US20040010139 Using iridium complex as hydrogenation catalyst |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040010014 Novel compounds as opioid receptor modulators |
| 01/15/2004 | US20040010013 Cannabinoid receptor ligands |
| 01/15/2004 | US20040010010 Melanocortin receptor ligands |
| 01/15/2004 | US20040010009 Excellent inhibitory activity against factor Xa |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | CA2491451A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 01/15/2004 | CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | CA2490463A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | CA2485379A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 01/14/2004 | EP1379587A1 Long chain hindered amines and compositions stabilized therewith |
| 01/14/2004 | EP1379519A1 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379515A1 Lipid lowering biphenylcarboxamides |
| 01/14/2004 | EP1379504A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | EP1379246A1 Nociceptin analogs |
| 01/14/2004 | EP1379237A2 Pyrrolidine sulfonamides |
| 01/14/2004 | EP1379234A1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
| 01/14/2004 | EP1286965B1 Piperidine compounds and process for providing such |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468222A N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3 receptor antagonists |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468220A New piperidine derivatives |
| 01/14/2004 | CN1468219A Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |